Your browser doesn't support javascript.
loading
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Moss, Paul; Berenbaum, Francis; Curigliano, Giuseppe; Grupper, Ayelet; Berg, Thomas; Pather, Shanti.
Affiliation
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK; Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, UK.
  • Berenbaum F; Sorbonne University, INSERM, AP-HP Saint-Antoine Hospital, Paris, France.
  • Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Grupper A; Department of Nephrology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Berg T; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, 04103 Leipzig, Germany.
  • Pather S; BioNTech SE, Mainz, Germany. Electronic address: shanti.pather@biontech.de.
Vaccine ; 40(32): 4348-4360, 2022 07 30.
Article in En | MEDLINE | ID: mdl-35718592
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vulnerable Populations / COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vulnerable Populations / COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Affiliation country: Country of publication: